Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1998 | 09-1998 | 06-1998 | 03-1998 | 12-1993 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 110 | 50 | 80 | 110 | 0 |
| TOTAL | $110 | $50 | $80 | $110 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 300 | 310 | 330 | 330 | N/A |
| TOTAL | $300 | $310 | $330 | $330 | $N/A |
| Total Assets | $410 | $360 | $410 | $440 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 580 | 3,090 | 3,080 | 2,550 | 61 |
| Accrued Expenses | 2,880 | 50 | 50 | 40 | 15 |
| Other current liabilities | 0 | 660 | 1,140 | 760 | 0 |
| TOTAL | $3,460 | $3,800 | $4,270 | $3,350 | $76 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 940 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $940 | $N/A |
| Total Liabilities | $3,460 | $3,800 | $4,270 | $4,290 | $76 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 60 | 60 | 60 | 12 |
| Other shareholders' equity | -2 | -1 | -2 | -1 | 0 |
| TOTAL | $39,998 | $31,549 | $30,928 | $30,309 | $5,884 |
| Total Liabilities And Equity | $43,458 | $35,349 | $35,198 | $34,599 | $5,960 |